141 related articles for article (PubMed ID: 2855408)
41. Molecular basis for the interaction of the hepatitis B virus core antigen with the surface immunoglobulin receptor on naive B cells.
Lazdina U; Cao T; Steinbergs J; Alheim M; Pumpens P; Peterson DL; Milich DR; Leroux-Roels G; Sällberg M
J Virol; 2001 Jul; 75(14):6367-74. PubMed ID: 11413303
[TBL] [Abstract][Full Text] [Related]
42. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
Scott DW; Livnat D; Whitin J; Dillon SB; Snyderman R; Pennell CA
J Mol Cell Immunol; 1987; 3(2):109-20. PubMed ID: 3509921
[TBL] [Abstract][Full Text] [Related]
43. Glycosylation is not required for membrane localization or secretion of IgM in a mouse B cell lymphoma.
Sibley CH; Wagner RA
J Immunol; 1981 May; 126(5):1868-73. PubMed ID: 6783700
[TBL] [Abstract][Full Text] [Related]
44. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
Finkelman FD; Mond JJ; Metcalf ES
J Immunol; 1983 Aug; 131(2):593-600. PubMed ID: 6602840
[TBL] [Abstract][Full Text] [Related]
45. The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).
Slavin S; Morecki S; Weiss L
J Immunol; 1980 Feb; 124(2):586-9. PubMed ID: 6965384
[TBL] [Abstract][Full Text] [Related]
46. The use of a monoclonal anti-idiotype antibody to study the biology of a human B cell lymphoma.
Hatzubai A; Maloney DG; Levy R
J Immunol; 1981 Jun; 126(6):2397-402. PubMed ID: 6785351
[TBL] [Abstract][Full Text] [Related]
47. A 30-kDa protein is disulfide linked to IgM on normal and neoplastic murine B lymphocytes.
Haustein D; Von der Ahe D
Eur J Immunol; 1986 Jan; 16(1):113-5. PubMed ID: 3485047
[TBL] [Abstract][Full Text] [Related]
48. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
49. Monoclonal antibodies to murine leukemia virus gp 70 recognize the same T lymphoma cell surface molecules as anti-immunoglobulin.
Baird S; Lesley J; Majda J; Raschke W
J Immunol; 1983 Sep; 131(3):1576-81. PubMed ID: 6604102
[TBL] [Abstract][Full Text] [Related]
50. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells.
Marches R; Racila E; Tucker TF; Picker L; Mongini P; Hsueh R; Vitetta ES; Scheuermann RH; Uhr JW
Ther Immunol; 1995 Jun; 2(3):125-36. PubMed ID: 8885131
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 2. The role of non-activated and rIL-2-activated CD4+ and CD8+ T cells in immunotherapy for leukemia.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):153-8. PubMed ID: 10641573
[TBL] [Abstract][Full Text] [Related]
52. A peptide difference between the mu-chains from cell-associated and secreted IgM of the BCL1 tumor.
Yuan D; Uhr JW; Vitetta ES
J Immunol; 1980 Jul; 125(1):40-6. PubMed ID: 6770002
[TBL] [Abstract][Full Text] [Related]
53. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
Kawamura H; Berzofsky JA
J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
[TBL] [Abstract][Full Text] [Related]
54. Characterization of a spontaneous murine B cell leukemia (BCL1). II. Tumor cell proliferation and IgM secretion after stimulation by LPS.
Knapp MR; Severinson-Gronowicz E; Schröder J; Strober S
J Immunol; 1979 Sep; 123(3):1000-6. PubMed ID: 381513
[TBL] [Abstract][Full Text] [Related]
55. Induction of differentiation in a B lymphoma X B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide.
Little J; Alling DW; Asofsky R
J Immunol; 1993 Mar; 150(6):2129-38. PubMed ID: 8450206
[TBL] [Abstract][Full Text] [Related]
56. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
Sinkovics JG
Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
[TBL] [Abstract][Full Text] [Related]
57. Murine B cell leukemia (BCL1): organ distribution and kinetics of growth as determined by fluorescence analysis with an anti-idiotypic antibody.
Krolick KA; Isakson PC; Uhr JW; Vitetta ES
J Immunol; 1979 Nov; 123(5):1928-35. PubMed ID: 385772
[TBL] [Abstract][Full Text] [Related]
58. Antigen-induced murine B cell lymphomas. II. Exploitation of the surface idiotype as tumor specific antigen.
Haughton G; Lanier LL; Babcock GF; Lynes MA
J Immunol; 1978 Dec; 121(6):2358-62. PubMed ID: 82581
[TBL] [Abstract][Full Text] [Related]
59. Activation of BCL1 cells by polyclonal activators and inhibition of growth and IgM secretion by anti-IgM.
Severinson E; Torres A; Möller G
Scand J Immunol; 1983 Aug; 18(2):153-62. PubMed ID: 6192491
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and characterization of membrane immunoglobulin, Ia, and H-2 molecules of thy 1+ AKR/J lymphomas.
Schwartz BD; Campbell PS; Asofsky R; Greenberg RS; Zatz MM
J Immunol; 1977 Nov; 119(5):1706-10. PubMed ID: 410882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
